Physician profile
Joseph Wayne Semien
NPI 1578793667
$11,088.37
in general payments reported to CMS, 2019-2025
22 companies · $3,209 in 2025
The $3,209 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $445 · 2021: $1,036 · 2022: $442 · 2023: $359 · 2024: $4,553 · 2025: $3,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,489 · Food and Beverage: $2,132 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,489.01 |
| Food and Beverage | $2,131.79 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,639.81 | 2024-2025 | |
| Boston Scientific Corporation | $4,124.08 | 2019-2024 | Solyx Sis System, Upsylon |
| Sanara Medtech INC. | $558.40 | 2020-2025 | Celleraterx, Biasurge |
| Coopersurgical, INC. | $276.74 | 2021-2025 | Cook, Ally II Ups, Sos |
| Abbvie INC. | $246.80 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $202.88 | 2022-2025 | |
| Evofem Biosciences, INC. | $195.31 | 2021-2025 | Phexxi, Solosec, Phexx |
| Astellas Pharma US INC | $149.22 | 2022-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $126.13 | 2022-2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Ethicon US, LLC | $114.53 | 2022-2025 | Enseal |
| Axonics, INC. | $90.24 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $70.44 | 2024 | Gemtesa |
| Merck Sharp & Dohme LLC | $66.13 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $49.60 | 2023-2024 | Exparel, Zilretta |
| Sage Therapeutics, LLC | $35.58 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $30.00 | 2022 | |
| Pfizer INC. | $27.41 | 2022 | |
| Coloplast Corp | $20.75 | 2024 | |
| Organon LLC | $19.55 | 2025 | Nexplanon |
| Millicent US INC | $15.79 | 2024 | Intrarosa, Femring |
| Daiichi Sankyo INC. | $14.52 | 2022 | |
| Lupin INC. | $14.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Semien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.